I've identified GOVX as a watch-worthy play with its tiny float and potential catalysts on the horizon. With the speculative nature of biotech, I'm pl...
Read
More
I've identified GOVX as a watch-worthy play with its tiny float and potential catalysts on the horizon. With the speculative nature of biotech, I'm placing a buy order for shares, anticipating significant movement if news breaks. This could lead to a big win for anyone willing to take the risk.
With the CEO increasing personal holdings and strong reports of monkeypox spreading, GOVX appears to be in a prime position to profit from potential v...
Read
More
With the CEO increasing personal holdings and strong reports of monkeypox spreading, GOVX appears to be in a prime position to profit from potential vaccination campaigns. Their active phase 2 trials add legitimacy, making it an intriguing short-term play given its low price point under $10.00.